Wenge Wang

6.7k total citations · 1 hit paper
111 papers, 5.0k citations indexed

About

Wenge Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenge Wang has authored 111 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 39 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenge Wang's work include Cancer-related Molecular Pathways (21 papers), Cell death mechanisms and regulation (13 papers) and Cancer Research and Treatments (10 papers). Wenge Wang is often cited by papers focused on Cancer-related Molecular Pathways (21 papers), Cell death mechanisms and regulation (13 papers) and Cancer Research and Treatments (10 papers). Wenge Wang collaborates with scholars based in United States, China and India. Wenge Wang's co-authors include Wafik S. El‐Deiry, David T. Dicker, Farzan Rastinejad, Gerard Apodaca, David H. Goetz, Jau-Yi Li, Kiyoshi Mori, Hediye Erdjument‐Bromage, Jonathan Barasch and Roland K. Strong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Wenge Wang

109 papers receiving 4.9k citations

Hit Papers

An Iron Delivery Pathway Mediated by a Lipocalin 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenge Wang United States 34 2.6k 1.5k 754 572 459 111 5.0k
Lanjing Zhang United States 28 2.2k 0.8× 2.8k 1.8× 1.2k 1.6× 488 0.9× 319 0.7× 126 5.0k
David Horst Germany 39 3.0k 1.2× 2.5k 1.6× 1.8k 2.4× 694 1.2× 380 0.8× 170 6.1k
Catherine O′Brien Canada 27 3.9k 1.5× 4.0k 2.7× 1.8k 2.4× 961 1.7× 334 0.7× 79 7.6k
Yan Huang China 34 2.7k 1.0× 864 0.6× 1.7k 2.3× 409 0.7× 354 0.8× 104 5.3k
Juan Wang China 34 2.1k 0.8× 795 0.5× 699 0.9× 749 1.3× 471 1.0× 186 4.2k
Mei Liu China 35 1.8k 0.7× 561 0.4× 559 0.7× 481 0.8× 353 0.8× 183 4.0k
Yanqing Ding China 48 5.5k 2.1× 1.8k 1.2× 3.5k 4.7× 870 1.5× 493 1.1× 191 9.4k
Steven M. Lipkin United States 39 3.9k 1.5× 1.7k 1.1× 1.5k 2.0× 441 0.8× 290 0.6× 107 6.2k
Y. Ann Chen United States 35 3.2k 1.2× 1.7k 1.1× 673 0.9× 864 1.5× 196 0.4× 109 5.3k

Countries citing papers authored by Wenge Wang

Since Specialization
Citations

This map shows the geographic impact of Wenge Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenge Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenge Wang more than expected).

Fields of papers citing papers by Wenge Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenge Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenge Wang. The network helps show where Wenge Wang may publish in the future.

Co-authorship network of co-authors of Wenge Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenge Wang. A scholar is included among the top collaborators of Wenge Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenge Wang. Wenge Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Bowen, et al.. (2025). Effectiveness and safety of dupilumab in the treatment of pediatric atopic dermatitis: a real-world study from China. Frontiers in Immunology. 16. 1644875–1644875. 1 indexed citations
2.
Wang, Wenge, et al.. (2023). Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report. Clinical Cosmetic and Investigational Dermatology. Volume 16. 1977–1981. 1 indexed citations
3.
Heibati, Behzad, Wenge Wang, Niilo Ryti, et al.. (2021). Weather conditions and COVID-19 incidence in a cold climate:a time-series study in Finland. University of Oulu Repository (University of Oulu). 12 indexed citations
5.
Cristea, Mihaela, Wenge Wang, Mark T. Wakabayashi, et al.. (2019). Highlights of the NCCN Oncology Research Program. Journal of the National Comprehensive Cancer Network. 17(1). xxxvii–xxxvii. 1 indexed citations
6.
Cristea, Mihaela, Wenge Wang, Mark T. Wakabayashi, et al.. (2019). Oncology Research Program. Journal of the National Comprehensive Cancer Network. 17(9). xxvi–xxvi. 1 indexed citations
7.
Wang, Yingying, et al.. (2019). Clinical epidemiology of renal disease in Gansu province base on 1828 renal biopsy data. 35(3). 212–214. 1 indexed citations
8.
Yin, Ming, et al.. (2017). Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study. BMC Cancer. 17(1). 295–295. 62 indexed citations
9.
Dower, Christopher M., et al.. (2016). Selective Reversible Inhibition of Autophagy in Hypoxic Breast Cancer Cells Promotes Pulmonary Metastasis. Cancer Research. 77(3). 646–657. 29 indexed citations
10.
Wang, Wenge, Todd D. Schell, Kathleen M. Kokolus, et al.. (2016). Malignant melanoma—The cradle of anti-neoplastic immunotherapy. Critical Reviews in Oncology/Hematology. 106. 25–54. 31 indexed citations
11.
Duan, Lei, et al.. (2015). Rating the quality of evidence: the GRADE system in systematic reviews/meta-analyses of AKI.. PubMed. 37(7). 1089–93. 2 indexed citations
12.
Peng, Yang, Hui Dai, Wenge Wang, et al.. (2014). TUSC4 Functions as a Tumor Suppressor by Regulating BRCA1 Stability. Cancer Research. 75(2). 378–386. 26 indexed citations
13.
Zhang, Bo, Wenge Wang, Hui Dai, et al.. (2013). BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer. Carcinogenesis. 34(10). 2271–2280. 13 indexed citations
14.
Strouch, Matthew J., Eric C. Cheon, Mohammad R. Salabat, et al.. (2010). Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression. Clinical Cancer Research. 16(8). 2257–2265. 149 indexed citations
15.
Gully, Christopher, Fanmao Zhang, Jian Chen, et al.. (2010). Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Molecular Cancer. 9(1). 42–42. 87 indexed citations
16.
Wang, Lihua, et al.. (2009). Investigation on the pyridinoline level in serum of experimental rats with articular cartilage damage. Chin J Endemiol. 28(6). 608–610. 1 indexed citations
17.
Laguinge, Luciana M., Raed Samara, Wenge Wang, et al.. (2008). DR5 Receptor Mediates Anoikis in Human Colorectal Carcinoma Cell Lines. Cancer Research. 68(3). 909–917. 40 indexed citations
18.
Wang, Wenge, William C. Ho, David T. Dicker, et al.. (2005). Acridine derivatives activate p53 and induce tumor cell death through bax. Cancer Biology & Therapy. 4(8). 893–898. 68 indexed citations
19.
Yang, Jun, David H. Goetz, Jau-Yi Li, et al.. (2002). An Iron Delivery Pathway Mediated by a Lipocalin. Molecular Cell. 10(5). 1045–1056. 539 indexed citations breakdown →
20.
Truschel, Steven T., Wenge Wang, Wily G. Ruiz, et al.. (2002). Stretch-regulated Exocytosis/Endocytosis in Bladder Umbrella Cells. Molecular Biology of the Cell. 13(3). 830–846. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026